Logo for HBM Holdings Limited

HBM Holdings Investor Relations Material

Latest events

Logo for HBM Holdings

H2 2024

31 Mar, 2025
Logo for HBM Holdings

H1 2024

28 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from HBM Holdings Limited

Access all reports
HBM Holdings Limited is a China-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative antibody therapeutics. The company utilizes its proprietary antibody technology platforms to develop a pipeline of monoclonal antibodies targeting various diseases, including cancer and autoimmune disorders. HBM Holdings conducts research and clinical development independently and through strategic partnerships in both domestic and international markets. The company is headquartered in Shanghai, China, and its shares are listed on the HKEX.